Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia
Clinical trial NCT02001818 · COMPLETED
Trial details
- NCT number
- NCT02001818
- Sponsor
- Australasian Leukaemia and Lymphoma Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-11
- Primary completion
- 2022-01-07
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.